Stella Pharma Corp. Hits Day High with 16.67% Surge in Stock Price

Stella Pharma Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge in its stock price, gaining 16.67% on March 18, 2026. The stock reached an intraday high of JPY 560.00, marking a notable performance against the backdrop of the Japan Nikkei 225, which rose by 2.87% on the same day. Over the past week, Stella Pharma has shown a robust increase of 13.36%, and its monthly performance stands at an impressive 27.85%. Year-to-date, the stock has soared by 175.86%, significantly outperforming the Nikkei 225's 9.73% gain. However, despite these short-term gains, the company faces challenges, including a negative return on equity and a concerning operating profit trend over the last five years. With a market capitalization of JPY 8,066 million, Stella Pharma's financial metrics indicate a complex landscape. The company has reported losses, reflected in its negative EBITDA and a low operating profit. As it navigates these financial hurdles, the stock's recent activity highlights the volatility and dynamics within the pharmaceutical sector.